Cargando…

VEGFR3 as a novel modulator for PAH

Detalles Bibliográficos
Autores principales:	Lee, Heon-Woo, Jin, Suk-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689546/ https://www.ncbi.nlm.nih.gov/pubmed/29156656 http://dx.doi.org/10.18632/oncotarget.21295

Ejemplares similares

Novel peptides suppress VEGFR-3 activity and antagonize VEGFR-3-mediated oncogenic effects
por: Chang, Yi-Wen, et al.
Publicado: (2014)

While your PAH patients skip by, don’t forget to check their rhythm …
por: Davey, Ryan
Publicado: (2018)

Cell autonomous Vegf-C/Vegfr3 signaling in adult neural stem cells
por: Kang, Tae Hyuk, et al.
Publicado: (2015)

Molecular characterization of Sin3 PAH-domain interactor specificity and identification of PAH partners
por: Le Guezennec, Xavier, et al.
Publicado: (2006)

Biodegradation of Mixed PAHs by PAH-Degrading Endophytic Bacteria
por: Zhu, Xuezhu, et al.
Publicado: (2016)

PAH Exposure
por: Fowler, Paul A., et al.
Publicado: (2009)

Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma
por: Lee, Chung-Han, et al.
Publicado: (2018)

The accumulation of metals, PAHs and alkyl PAHs in the roots of Echinacea purpurea
por: Pretorius, Travers R., et al.
Publicado: (2018)

VEGFR-2: One of Pioglitazone’s Signaling Pathways in the Heart
por: Minicucci, Marcos Ferreira, et al.
Publicado: (2018)

Targeting VEGF/VEGFR to Modulate Antitumor Immunity
por: Yang, Ju, et al.
Publicado: (2018)

Decursin inhibits retinal neovascularization via suppression of VEGFR-2 activation
por: Kim, Jeong Hun, et al.
Publicado: (2009)

VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis
por: Jang, Jeon Yeob, et al.
Publicado: (2017)

Utilization of risk assessment tools in management of PAH: A PAH provider survey
por: Sahay, Sandeep, et al.
Publicado: (2022)

Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Novel Advances in Modifying BMPR2 Signaling in PAH
por: Dannewitz Prosseda, Svenja, et al.
Publicado: (2020)

PAH cleanup in Illinois.
por: O'Brien, J P
Publicado: (1994)

Risk stratification in PAH
por: Corris, Paul A.
Publicado: (2020)

Vitamin D Enhances Anticancer Properties of Cediranib, a VEGFR Inhibitor, by Modulation of VEGFR2 Expression in Melanoma Cells
por: Piotrowska, Anna, et al.
Publicado: (2021)

Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation
por: Dieterich, Lothar C., et al.
Publicado: (2017)

Walking the tightrope of bioavailability: growth dynamics of PAH degraders on vapour‐phase PAH
por: Hanzel, Joanna, et al.
Publicado: (2012)

Multimedia Model for Polycyclic Aromatic Hydrocarbons (PAHs) and Nitro-PAHs in Lake Michigan
por: Huang, Lei, et al.
Publicado: (2014)

Biodegradation Potential of Bacillus sp. PAH-2 on PAHs for Oil-Contaminated Seawater
por: Kong, Xianghui, et al.
Publicado: (2022)

Counterbalance: modulation of VEGF/VEGFR activities by TNFSF15
por: Yang, Gui-Li, et al.
Publicado: (2018)

VEGFR2 trafficking: Speed doesn’t kill
por: Zhang, Xi, et al.
Publicado: (2013)

PAH/PAH(CF(3))(n) Donor/Acceptor Charge‐Transfer Complexes in Solution and in Solid‐State Co‐Crystals
por: Castro, Karlee P., et al.
Publicado: (2019)

Ras/MAPK Signaling Modulates VEGFR-3 Expression through Ets-Mediated p300 Recruitment and Histone Acetylation on the Vegfr3 Gene in Lymphatic Endothelial Cells
por: Ichise, Taeko, et al.
Publicado: (2012)

VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
por: D'Haene, Nicky, et al.
Publicado: (2013)

Intramembrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the endothelial mechanosensory complex
por: Coon, Brian G., et al.
Publicado: (2015)

TIMP-2 Modulates VEGFR-2 Phosphorylation and Enhances Phosphodiesterase Activity in Endothelial Cells
por: Lee, Seo-Jin, et al.
Publicado: (2010)

Extended therapy breaks from VEGFR TKI therapy in renal cell carcinoma: Sometimes less is more
por: Zahoor, Haris, et al.
Publicado: (2017)

A Novel Variant in the PAH Gene Causing Phenylketonuria in an Iranian Pedigree
por: Alavinejad, Elaheh, et al.
Publicado: (2017)

Mud volcanoes and the presence of PAHs
por: Remizovschi, Alexei, et al.
Publicado: (2020)

VEGFR-2 reduces while combined VEGFR-2 and -3 signaling increases inflammation in apical periodontitis
por: Virtej, Anca, et al.
Publicado: (2016)

Quantitative assessment data of PAHs and N-PAHs in core sediments from the Niger Delta, Nigeria
por: Anyanwu, Ihuoma N., et al.
Publicado: (2020)

Polycyclic Aromatic Hydrocarbons (PAHs) in Roasted Pork Meat and the Effect of Dried Fruits on PAH Content
por: Bulanda, Sylwia, et al.
Publicado: (2023)

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
por: Steeghs, Neeltje, et al.
Publicado: (2009)

Pro-lymphangiogenic VEGFR-3 signaling modulates memory T cell responses in allergic airway inflammation
por: Maisel, Katharina, et al.
Publicado: (2020)

The Emergence of Different Functionally Equivalent PAH Degrading Microbial Communities from a Single Soil in Liquid PAH Enrichment Cultures and Soil Microcosms Receiving PAHs with and without Bioaugmentation
por: PIUBELI, FRANCINE AMARAL, et al.
Publicado: (2018)

VEGFR-3 Expression in Oral Lichen Planus
por: Saravi, Zahra Zolfaghari, et al.
Publicado: (2017)

Polycyclic aromatic hydrocarbons (PAHs), nitro-PAHs and related environmental compounds: biological markers of exposure and effects.
por: Talaska, G, et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_aj217f1914k1kbfb5j7lo0vj08